BOARD MEMBER

Dan Marks, PhD

Venture Associate, RA Capital Management

Dan Marks is a Venture Associate within the Venture team at RA Capital Management. Dan’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Dan holds a BS with Honors in Biology from Yale University and a PhD in Cancer Biology from the Gerstner Sloan Kettering School of Biomedical Sciences. His graduate research focused on identifying novel targets for disrupting the cell cycle in cancer cells.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close